Jin Hou, PhD

Institute of Immunology
Institute of Immunology, Second Military Medical University.
Shanghai China 200433

Any personal financial relationships? Yes

Organization Name Relationship

NSFC 6

Organization Name	Relationship
NSFC	6

I have disclosed to ICMI all relevant financial relationships, and hereby allow ICMI to disclose this information to learners in print.

I agree to provide educational content and resources in advance for review if requested by ICMI.

To the best of my ability, I will ensure that any speakers or content I suggest is independent of commercial bias.

1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.

2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).

3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.

4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 04/02/2015 by Jin Hou

Papers:
OR.91 Inhibition of miR-93 Promotes Interferon Effector Signaling to Suppress Influenza A Infection by Upregulating JAK1

	I have disclosed to ICMI all relevant financial relationships, and hereby allow ICMI to disclose this information to learners in print.
	I agree to provide educational content and resources in advance for review if requested by ICMI.
	To the best of my ability, I will ensure that any speakers or content I suggest is independent of commercial bias.
	1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
	2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
	3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
	4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".